- Home
- ATNI vs MXCT Comparison
ATNI vs MXCT Comparison
Compare ATNI & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNI
- MXCT
- Stock Information
- Founded
- ATNI 1987
- MXCT 1999
- Country
- ATNI United States
- MXCT United States
- Employees
- ATNI N/A
- MXCT N/A
- Industry
- ATNI Telecommunications Equipment
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ATNI Telecommunications
- MXCT Health Care
- Exchange
- ATNI Nasdaq
- MXCT Nasdaq
- Market Cap
- ATNI 312.7M
- MXCT 275.7M
- IPO Year
- ATNI 1991
- MXCT 2021
- Fundamental
- Price
- ATNI $17.64
- MXCT $2.90
- Analyst Decision
- ATNI Strong Buy
- MXCT Strong Buy
- Analyst Count
- ATNI 2
- MXCT 2
- Target Price
- ATNI $31.00
- MXCT $10.00
- AVG Volume (30 Days)
- ATNI 57.5K
- MXCT 666.3K
- Earning Date
- ATNI 04-30-2025
- MXCT 05-07-2025
- Dividend Yield
- ATNI 5.62%
- MXCT N/A
- EPS Growth
- ATNI N/A
- MXCT N/A
- EPS
- ATNI N/A
- MXCT N/A
- Revenue
- ATNI $729,075,000.00
- MXCT $38,627,000.00
- Revenue This Year
- ATNI $1.85
- MXCT $9.05
- Revenue Next Year
- ATNI $1.51
- MXCT $19.98
- P/E Ratio
- ATNI N/A
- MXCT N/A
- Revenue Growth
- ATNI N/A
- MXCT N/A
- 52 Week Low
- ATNI $14.74
- MXCT $2.21
- 52 Week High
- ATNI $33.72
- MXCT $5.26
- Technical
- Relative Strength Index (RSI)
- ATNI 42.02
- MXCT 53.27
- Support Level
- ATNI $16.83
- MXCT $2.29
- Resistance Level
- ATNI $18.10
- MXCT $2.74
- Average True Range (ATR)
- ATNI 0.80
- MXCT 0.22
- MACD
- ATNI -0.04
- MXCT 0.08
- Stochastic Oscillator
- ATNI 46.29
- MXCT 91.95
About ATNI ATN International Inc.
ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise U.S. Telecom and International Telecom. The company earns revenue from its International telecommunication segment.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.